Concourse Financial Group Securities, Inc. Apellis Pharmaceuticals, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$28.84 - $41.15 $28 - $41	-1 Closed	0 $0
Q3 2023 Oct 25, 2023	BUY	$23.65 - $89.22 $23 - $89	1 New	1 $0
Q2 2023 Aug 10, 2023	BUY	$76.68 - $93.31 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$46.59 - $66.96 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$43.24 - $61.04 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$44.76 - $69.66 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$35.07 - $59.21 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$35.46 - $54.12 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$30.74 - $49.16 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	BUY	$31.4 - $69.84 $0 - $0	0 New	0 $0
Q2 2021 Aug 13, 2021	BUY	$40.9 - $64.9 $0 - $0	0 New	0 $0
Q1 2021 May 13, 2021	BUY	$40.8 - $57.39 $0 - $0	0 New	0 $0
Q4 2020 Feb 02, 2021	BUY	$30.79 - $57.2 $0 - $0	0 New	0 $0
Q3 2020 Nov 13, 2020	BUY	$25.89 - $33.65 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$24.8 - $38.49 $0 - $0	0 New	0 $0
Q1 2020 May 13, 2020	BUY	$17.91 - $44.33 $0 - $0	0 New	0 $0
Q4 2019 Feb 14, 2020	BUY	$22.1 - $30.8 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$24.09 - $32.18 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$18.0 - $25.34 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	BUY	$12.81 - $19.82 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$11.47 - $18.71 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$16.57 - $21.03 $0 - $0	0 New	0 $0

Others Institutions Holding APLS

# of Institutions

301

Shares Held

114M

Call Options Held

5.21M

Put Options Held

691K

Wellington Management Group LLP Boston, MA

16.4M
Shares

$471 Million
0.11% of portfolio
Eco R1 Capital, LLC San Francisco, CA

11.6M
Shares

$334 Million
15.74% of portfolio
Avoro Capital Advisors LLC New York, NY

11.1M
Shares

$319 Million
5.82% of portfolio
Vanguard Group Inc Valley Forge, PA

9.81M
Shares

$282 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.8M
Shares

$167 Million
0.01% of portfolio

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.16B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account